详情页 - 首都医科大学宣武医院知识库

资源类型：

文章类型：

作者：

Jiang, Zhichao[1,2,3,4,5,6,7,8,9,10,11,12] * ; Wei, Deng[1,2,3,4,5,6,7,8,9,10,11,12] ; Sun, Yongkun[1,2,3,4,5,6,7,8,9,10,11,12] ; Cheng, Jianping[1,2,3,4,5,6,7,8,9,10,11,12] ; Zhang, Wen[1,2,3,4,5,6,7,8,9,10,11,12] ; Bai, Chunmei[1,2,3,4,5,6,7,8,9,10,11,12] ; Niu, Zuoxing[1,2,3,4,5,6,7,8,9,10,11,12] ; Zhu, Chunrong[1,2,3,4,5,6,7,8,9,10,11,12]

; Wu, Rong[1,2,3,4,5,6,7,8,9,10,11,12] ; Chen, Xiaobing[1,2,3,4,5,6,7,8,9,10,11,12] ; Zhang, Yan[1,2,3,4,5,6,7,8,9,10,11,12]

; Li, Sheng[1,2,3,4,5,6,7,8,9,10,11,12]

; Huang, Yingying[1,2,3,4,5,6,7,8,9,10,11,12] ; Zhou, Jianfeng[1,2,3,4,5,6,7,8,9,10,11,12] ; Shi, Shengbin[1,2,3,4,5,6,7,8,9,10,11,12] ; Xiong, Feng[1,2,3,4,5,6,7,8,9,10,11,12] ; Zhao, Yun-Bo[1,2,3,4,5,6,7,8,9,10,11,12] ; Zhu, Liangjun[1,2,3,4,5,6,7,8,9,10,11,12] ; Zhou, Ai-Ping[1,2,3,4,5,6,7,8,9,10,11,12] ;

机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China [2]Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, Beijing, Peoples R China [3]Civil Aviat Gen Hosp, Dept Gastroenterol & Oncol, Beijing, Peoples R China [4]Peking Union Med Coll Hosp, Dept Oncol, Beijing, Peoples R China [5]Shandong Canc Hosp, Internal Med Ward 4, Jinan, Peoples R China [6]Soochow Univ, Dept Med Oncol, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China [7]China Med Univ, Dept Oncol, Shengjing Hosp, Shenyang, Peoples R China [8]Zhengzhou Univ, Henan Canc Hosp, Dept Internal Oncol, Affiliated Canc Hosp, Zhengzhou, Peoples R China [9]Capital Med Univ, Dept Gen Surg, Xuanwu Hosp, Beijing, Peoples R China [10]Nanjing Med Univ, Dept Internal Med, Jiangsu Canc Hosp, Jiangsu Inst Canc Res,Affiliated Canc Hosp, Nanjing, Peoples R China [11]Minist Hlth, Beijing Hosp, Oncol Dept, Beijing, Peoples R China [12]Peking Union Med Coll Hosp, Dept Med Oncol, Beijing, Peoples R China

出处：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2021]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2020]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China [2]Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, Beijing, Peoples R China [3]Civil Aviat Gen Hosp, Dept Gastroenterol & Oncol, Beijing, Peoples R China [4]Peking Union Med Coll Hosp, Dept Oncol, Beijing, Peoples R China [5]Shandong Canc Hosp, Internal Med Ward 4, Jinan, Peoples R China [6]Soochow Univ, Dept Med Oncol, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China [7]China Med Univ, Dept Oncol, Shengjing Hosp, Shenyang, Peoples R China [8]Zhengzhou Univ, Henan Canc Hosp, Dept Internal Oncol, Affiliated Canc Hosp, Zhengzhou, Peoples R China [9]Capital Med Univ, Dept Gen Surg, Xuanwu Hosp, Beijing, Peoples R China [10]Nanjing Med Univ, Dept Internal Med, Jiangsu Canc Hosp, Jiangsu Inst Canc Res,Affiliated Canc Hosp, Nanjing, Peoples R China [11]Minist Hlth, Beijing Hosp, Oncol Dept, Beijing, Peoples R China [12]Peking Union Med Coll Hosp, Dept Med Oncol, Beijing, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Biweekly mXELIRI versus FOLFIRI in combination with bevacizumab as the first-line treatment for metastatic colorectal cancer (EXIST): A multicenter, randomized, open-label, phase 2 study

文献详情